Juq-063 Jun 2026

Intermittent fasting (IF) is an eating pattern that cycles between periods of fasting and eating. It focuses on you eat rather than specifically 1. Choose Your Protocol

| Area | Rationale | |------|-----------| | | As a high‑affinity CB₁/CB₂ agonist, JUQ‑063 can help elucidate receptor signaling pathways, bias signaling, and the role of cannabinoid receptors in pain and inflammation. | | Structure‑activity relationship (SAR) studies | The indazole‑carboxamide scaffold offers a versatile platform for exploring modifications that affect potency, selectivity, and metabolic stability. | | Drug‑delivery investigations | Its lipophilicity makes it a candidate for formulation studies (e.g., nano‑emulsions, transdermal patches) aimed at targeted cannabinoid delivery. | | Toxicology testing | Provides a model compound for assessing the health risks associated with new synthetic cannabinoids entering the market. | JUQ-063

The numbers typically represent the specific sequence or iteration. "063" could mean the 63rd batch, the 63rd model revision, or a specific location code within a warehouse grid. 🚀 Benefits of Serialized Coding Systems Intermittent fasting (IF) is an eating pattern that